To assess the effects of AAV9‐TRF1 gene therapy on cancer incidence, we performed a full pathological analysis at the time of death in both AAV9‐TRF1‐ and AAV9‐empty‐treated mouse cohorts. This evidence concerns the gene TERF1 and cancer.